+29.1%
MRNA vs GRMN
+179.1%
-149.9%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | GRMN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | 0.0% | +0.7% | +0.7% |
| 7D | -8.2% | -1.8% | -6.4% | -7.6% |
| 30D | +125.6% | -12.1% | +137.7% | +136.1% |
| 3M | +197.1% | +18.0% | +179.1% | +173.7% |
| 6M | +148.5% | +13.7% | +134.8% | +132.5% |
| YTD | +363.3% | +35.3% | +328.0% | +304.0% |
| 1Y | +462.0% | +17.2% | +444.7% | +416.3% |
| All | +29.1% | +179.1% | -149.9% | -7.7% |
Cumulative growth
Daily Returns
Daily percentage return beside GRMN.
Daily Out/Under-Performance
Portfolio return minus GRMN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GRMN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded GRMN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling